Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease
暂无分享,去创建一个
M. Feldman | M. Kawano | W. Lipkin | A. Fosså | Federico Valdivieso | F. van Rhee | D. Shilling | J. Ruth | C. Nabel | K. Stone | D. Fajgenbaum | A. Chadburn | S. Spetalen | Yasuharu Sato | S. Sameroff | D. Alapat | Y. Sato | W. Lipkin | Michael D. Feldman | W. I. Lipkin
[1] J. V. Moran,et al. Mobile DNA in Health and Disease , 2017, The New England journal of medicine.
[2] K. Young,et al. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. , 2017, Blood.
[3] J. Rossi,et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. , 2017, Blood.
[4] E. Kirkness,et al. The blood DNA virome in 8,000 humans , 2017, PLoS pathogens.
[5] Jennifer K. Sun,et al. Out of Sight: Culture-Negative Endocarditis and Endophthalmitis. , 2017, The American journal of medicine.
[6] G. Antonelli,et al. Torquetenovirus: the human virome from bench to bedside. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[7] W. Lipkin,et al. Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis , 2015, mBio.
[8] W. Lipkin,et al. A Vision for Investigating the Microbiology of Health and Disease. , 2015, The Journal of infectious diseases.
[9] Joseph L DeRisi,et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. , 2014, The New England journal of medicine.
[10] F. van Rhee,et al. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. , 2014, Blood.
[11] M. Kojima,et al. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012 , 2013, Journal of clinical and experimental hematopathology : JCEH.
[12] É. Oksenhendler,et al. Human herpesvirus 8-related Castleman disease in the absence of HIV infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Jie Jin,et al. High prevalence of hepatitis B virus infection in HIV-negative Castleman's disease , 2012, Annals of Hematology.
[14] Jack T. Stapleton,et al. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae , 2011, The Journal of general virology.
[15] M. Bower,et al. Fifty years of multicentric Castleman's disease , 2004, Acta oncologica.
[16] L. Young,et al. Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.
[17] P. Murray,et al. Hodgkin's disease and the Epstein-Barr virus , 2000, Molecular pathology : MP.
[18] É. Oksenhendler,et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. , 2000, Blood.
[19] Jonathan J. Lewis,et al. The management of unicentric and multicentric Castleman's disease , 1999, Cancer.
[20] M. Corbellino,et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. , 1997, The American journal of pathology.
[21] V. Calvez,et al. Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. , 1997, The Journal of infectious diseases.
[22] C. Boshoff,et al. Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.
[23] R. Marasca,et al. Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease , 1996, Clinical molecular pathology.
[24] J. Soulier,et al. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients , 1996, AIDS.
[25] L. Young,et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells , 1993, The Journal of experimental medicine.
[26] R. Scully,et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. , 1976, The New England journal of medicine.
[27] B. Castleman,et al. Localized mediastinal lymph‐node hyperplasia resembling thymoma , 1956, Cancer.
[28] W. Lipkin,et al. Virus hunting. , 2015, Virology.
[29] P. Davies,et al. Journal of Cardiothoracic Surgery BioMed Central , 2009 .
[30] L. Young,et al. Localization of Epstein-Barr virus in Castleman's disease by in situ hybridization and immunohistochemistry. , 1995, Hematologic pathology.
[31] B. Birmingham. Epstein-Barr Virus and Hodgkin's Disease: Transcriptional Analysis of Virus Latency in the Malignant Cells By E. M. Deacon, G. Pallesen,* G. Niedobitek,~ J. Crocker, g L. Brooks, A. B. Rickinson, and L. S. Young , 1993 .
[32] R. Stein,et al. Multicentric giant lymph node hyperplasia. , 1978, American journal of clinical pathology.